![Immune Network Ltd Logo](/news-release/logo/214799/0/214799.jpg?lastModified=12%2F09%2F2016%2023%3A15%3A24&size=2)
Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5
November 14, 2010 23:21 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 14, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has announced the completion of...
![Immune Network Ltd Logo](/news-release/logo/214799/0/214799.jpg?lastModified=12%2F09%2F2016%2023%3A15%3A24&size=2)
Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week
November 01, 2010 09:42 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...
SafeShot Technologies Files Patents on New Low-Dose Version of Its Revolutionary Safety Injection Technology Called "Epiphany Ultra"
September 14, 2010 09:45 ET
|
SafeShot Technologies
MISSION VIEJO, CA--(Marketwire - September 14, 2010) - SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced the successful development and patent filings on a new...
IMSCO Issues License for Detection and Removal of Viral and Bacterial Contaminants in Blood and Blood Products
August 26, 1999 12:31 ET
|
IMSCO Technologies
NEW YORK, Aug. 26, 1999 (PRIMEZONE) -- IMSCO has issued a license for its unique proprietary electrostatic separation technology to BIOELECTRIC SEPARATION, INC., (BSI) a New York Corporation and...